Pandemic risks from bird flu

British Medical Journal

Volumn 328, Issue 7434, 2004, Pages 238-239

  Barclay, Wendy S ^a   Zambon, Maria ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; SIALIDASE INHIBITOR;

BIRD DISEASE; DISEASE TRANSMISSION; EDITORIAL; EPIDEMIC; GENE THERAPY; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 0842330284     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7434.238     Document Type: Editorial

References (4)

1. Hatta M, Gao P, Halfman P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001;293:1840-2.
2. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nature Medicine 2002;8:950-4.
3. Cheung CY, Poon LLM, Lau AS, Luk W, Lau YL, Shortridge KF, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002;360:1831-7.
4. Webster RG. Wet markets - a continuing source of severe acute respiratory syndrome and influenza? Lancet 2004;363:234-6.